skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 40,929  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Life Sciences & Biomedicine remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
Material Type:
Article
Add to My Research

Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5

Cell, 2022-10, Vol.185 (21), p.3992-4007.e16 [Peer Reviewed Journal]

2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s) 2022 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2022.09.018 ;PMID: 36198317

Full text available

2
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
Material Type:
Article
Add to My Research

Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant

Cell host & microbe, 2022-11, Vol.30 (11), p.1540-1555.e15 [Peer Reviewed Journal]

2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s). Published by Elsevier Inc. 2022 ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2022.10.003 ;PMID: 36272413

Full text available

3
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance
Material Type:
Article
Add to My Research

The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance

Cell reports (Cambridge), 2022-01, Vol.38 (2), p.110218-110218, Article 110218 [Peer Reviewed Journal]

2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2021.110218 ;PMID: 34968415

Full text available

4
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
Material Type:
Article
Add to My Research

Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike

Cell, 2022-06, Vol.185 (12), p.2103-2115.e19 [Peer Reviewed Journal]

2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 The Author(s) 2022 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2022.04.035 ;PMID: 35568035

Digital Resources/Online E-Resources

5
Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant
Material Type:
Article
Add to My Research

Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant

The Lancet infectious diseases, 2023-03, Vol.23 (3), p.280-281 [Peer Reviewed Journal]

2023 Elsevier Ltd ;2023. Elsevier Ltd ;2023 Elsevier Ltd. All rights reserved. 2023 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(23)00051-8 ;PMID: 36736338

Full text available

6
Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir
Material Type:
Article
Add to My Research

Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir

PLoS pathogens, 2023-03, Vol.19 (3), p.e1011231-e1011231 [Peer Reviewed Journal]

Copyright: © 2023 Torii et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2023 Public Library of Science ;2023 Torii et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Torii et al 2023 Torii et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1011231 ;PMID: 36972312

Full text available

7
Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant
Material Type:
Article
Add to My Research

Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant

The Lancet infectious diseases, 2023-11, Vol.23 (11), p.e460-e461 [Peer Reviewed Journal]

2023 Elsevier Ltd ;2023. Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(23)00575-3

Full text available

8
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
Material Type:
Article
Add to My Research

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

The Lancet (British edition), 2022-04, Vol.399 (10335), p.1607-1617 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02333-3 ;PMID: 35461558

Full text available

9
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
Material Type:
Article
Add to My Research

Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum

New England Journal of Medicine, 2021-12, Vol.385 (25), p.2397-2399 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2114706 ;PMID: 34731554

Digital Resources/Online E-Resources

10
Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
Material Type:
Article
Add to My Research

Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies

The Lancet infectious diseases, 2022-07, Vol.22 (7), p.942-943 [Peer Reviewed Journal]

2022 Elsevier Ltd ;2022. Elsevier Ltd ;2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00365-6 ;PMID: 35690075

Full text available

11
The Natural Course of Unruptured Cerebral Aneurysms in a Japanese Cohort
Material Type:
Article
Add to My Research

The Natural Course of Unruptured Cerebral Aneurysms in a Japanese Cohort

The New England journal of medicine, 2012-06, Vol.366 (26), p.2474-2482 [Peer Reviewed Journal]

Copyright © 2012 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1113260 ;PMID: 22738097 ;CODEN: NEJMAG

Full text available

12
Leveraging fine-mapping and multipopulation training data to improve cross-population polygenic risk scores
Material Type:
Article
Add to My Research

Leveraging fine-mapping and multipopulation training data to improve cross-population polygenic risk scores

Nature genetics, 2022-04, Vol.54 (4), p.450-458 [Peer Reviewed Journal]

2022. The Author(s), under exclusive licence to Springer Nature America, Inc. ;Copyright Nature Publishing Group Apr 2022 ;ISSN: 1061-4036 ;EISSN: 1546-1718 ;DOI: 10.1038/s41588-022-01036-9 ;PMID: 35393596

Full text available

13
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study
Material Type:
Article
Add to My Research

Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study

Journal of clinical oncology, 2020-01, Vol.38 (2), p.115-123 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.01488 ;PMID: 31682542

Full text available

14
Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study
Material Type:
Article
Add to My Research

Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study

Brain (London, England : 1878), 2020-05, Vol.143 (5), p.1431-1446 [Peer Reviewed Journal]

The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0006-8950 ;EISSN: 1460-2156 ;DOI: 10.1093/brain/awaa102 ;PMID: 32412053

Full text available

15
Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis
Material Type:
Article
Add to My Research

Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis

Nature genetics, 2022-11, Vol.54 (11), p.1640-1651 [Peer Reviewed Journal]

2022. The Author(s), under exclusive licence to Springer Nature America, Inc. ;Copyright Nature Publishing Group Nov 2022 ;ISSN: 1061-4036 ;ISSN: 1546-1718 ;EISSN: 1546-1718 ;DOI: 10.1038/s41588-022-01213-w ;PMID: 36333501

Full text available

16
Virological characteristics of the SARS-CoV-2 JN.1 variant
Material Type:
Article
Add to My Research

Virological characteristics of the SARS-CoV-2 JN.1 variant

The Lancet infectious diseases, 2024-02, Vol.24 (2), p.e82-e82 [Peer Reviewed Journal]

2024. Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/s1473-3099(23)00813-7 ;PMID: 38184005

Full text available

17
Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study)
Material Type:
Article
Add to My Research

Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study)

Japanese journal of clinical oncology, 2013-07, Vol.43 (7), p.752-755 [Peer Reviewed Journal]

ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyt061 ;PMID: 23625063

Full text available

18
Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis
Material Type:
Article
Add to My Research

Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis

Journal of gastroenterology, 2014-06, Vol.49 (6), p.961-970 [Peer Reviewed Journal]

Springer Japan 2014 ;COPYRIGHT 2014 Springer ;ISSN: 0944-1174 ;EISSN: 1435-5922 ;DOI: 10.1007/s00535-014-0945-z ;PMID: 24639058

Full text available

19
East Asian-specific and cross-ancestry genome-wide meta-analyses provide mechanistic insights into peptic ulcer disease
Material Type:
Article
Add to My Research

East Asian-specific and cross-ancestry genome-wide meta-analyses provide mechanistic insights into peptic ulcer disease

Nature genetics, 2023-12, Vol.55 (12), p.2129-2138 [Peer Reviewed Journal]

2023. The Author(s). ;Copyright Nature Publishing Group Dec 2023 ;ISSN: 1061-4036 ;EISSN: 1546-1718 ;DOI: 10.1038/s41588-023-01569-7 ;PMID: 38036781

Full text available

20
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion
Material Type:
Article
Add to My Research

SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion

The Journal of infectious diseases, 2021-09, Vol.224 (6), p.989-994 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. 2021 ;The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiab368 ;PMID: 34260717

Full text available

Results 1 - 20 of 40,929  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (34,260)

Refine My Results

Creation Date 

From To
  1. Before 1972  (74)
  2. 1972 To 1984  (5,448)
  3. 1985 To 1997  (14,253)
  4. 1998 To 2011  (18,822)
  5. After 2011  (2,342)
  6. More options open sub menu

Resource Type 

  1. Articles  (40,921)
  2. Books  (4)
  3. magazinearticle  (3)
  4. Conference Proceedings  (1)
  5. More options open sub menu

Language 

  1. English  (38,334)
  2. Japanese  (24,778)
  3. Chinese  (116)
  4. Turkish  (12)
  5. Portuguese  (8)
  6. French  (6)
  7. German  (6)
  8. Dutch  (6)
  9. Czech  (5)
  10. Slovak  (4)
  11. Norwegian  (3)
  12. Italian  (2)
  13. Russian  (1)
  14. Spanish  (1)
  15. More options open sub menu

Searching Remote Databases, Please Wait